You have been chosen to receive this valuable information. |
|
|
|
|
The ABCs (and D) of Avoiding
Out-of-Specification Results
|
|
|
The discovery of an out-of-specification result (OOS) can be extremely damaging – and costly – for the pharma manufacturing process. OOS results can trigger an investigation, which brings all violation-related activities to a standstill. In some cases, an OOS can even delay a batch release.
Download our checklist, "The ABCs (and D) of Avoiding Out-of-Specification Results," for some tips and techniques for limiting OOS results and avoiding delays. We’ll show you the best way to keep your lab running at peak productivity while ensuring your products’ continued success.
|
|
|
|
|
|
|
|
|
© 2020 PerkinElmer, Inc. All rights reserved.
PerkinElmer, Inc. | 940 Winter Street | Waltham, MA 02451 USA | www.perkinelmer.com
|
|
|
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Executive, an MJH Life Sciences™ brand. You are on the mailing list as %%emailaddress%%.
|
|
